OLMETEC

This brand name is authorized in Albania, Australia, Brazil, Canada, Ecuador, Finland, France, Germany, Hong Kong SAR China, Italy, Japan, Netherlands, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug OLMETEC contains one active pharmaceutical ingredient (API):

1	Olmesartan medoxomil UNII 6M97XTV3HD - OLMESARTAN MEDOXOMIL
	Olmesartan medoxomil is a potent, orally active, selective angiotensin II receptor (type AT1) antagonist. It is expected to block all actions of angiotensin II mediated by the AT1 receptor, regardless of the source or route of synthesis of angiotensin II. The selective antagonism of the angiotensin II (AT1) receptors results in increases in plasma renin levels and angiotensin I and II concentrations, and some decrease in plasma aldosterone concentrations.
	Read more about Olmesartan medoxomil

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
OLMETEC Film-coated tablet	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C09CA08	Olmesartan medoxomil	C Cardiovascular system → C09 Agents acting on the renin-angiotensin system → C09C Angiotensin II antagonists, plain → C09CA Angiotensin II antagonists, plain
Discover more medicines within C09CA08

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AL	Fondi i Sigurimit të Detyrueshëm të Kujdesit Shëndetësor	402/463
AU	Pharmaceutical Benefits Scheme	2147B, 2148C
BR	Câmara de Regulação do Mercado de Medicamentos	522718010072617, 522718010072717, 522718010072817, 522718010072917
CA	Health Products and Food Branch	02318660, 02318679
DE	Bundesinstitut für Arzneimittel und Medizinprodukte	00096603, 00102491, 00177081, 00204027, 00497621, 00754199, 00754236, 00754242, 01988893, 02129206, 02154836, 02154859, 02231146, 02231175, 02231198, 02231212, 02231413, 02231442, 02759551, 04787758, 05356351, 05371362, 05523702, 06138018, 06572743, 06572789, 06572826, 06574541, 06574570, 06906032, 07544252, 07544269, 14030743, 14235310, 14235327, 14441860, 16002633
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	27.029-05-06, 27.030-05-06
ES	Centro de información online de medicamentos de la AEMPS	036027112, 65492, 65496, 65497
FI	Lääkealan turvallisuus- ja kehittämiskeskus	018311, 018446, 018502, 018512, 018534, 018586
FR	Base de données publique des médicaments	66152197, 67258011, 68573412
GB	Medicines & Healthcare Products Regulatory Agency	139419, 139423, 146690, 146694, 162173, 162177, 196971, 198581, 46241, 46244, 46247
HK	Department of Health Drug Office	53022, 53023, 53024
IT	Agenzia del Farmaco	036027011, 036027062, 036027112
JP	医薬品医療機器総合機構	2149044F5020, 2149044F6026, 2149044F7022, 2149044F8029
NL	Z-Index G-Standaard, PRK	70181, 70203, 70211
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W67484001, W67484002, W67484003, W67484004, W67485001, W67485002, W67485003, W67485004, W67486001, W67486002, W67486003, W67486004
SG	Health Sciences Authority	13016P, 13018P
TN	Direction de la Pharmacie et du Médicament	12803031, 12803032, 12803033
TR	İlaç ve Tıbbi Cihaz Kurumu	8699228090126, 8699228090133, 8699228090140, 8699228090157, 8699228090164, 8699228090195, 8699228090201, 8699228090218, 8699228090225, 8699228090232
ZA	Health Products Regulatory Authority	40/7.1.3/0405, A40/7.1.3/0403, A40/7.1.3/0404